PMID- 29484382 OWN - NLM STAT- MEDLINE DCOM- 20180827 LR - 20181202 IS - 1791-244X (Electronic) IS - 1107-3756 (Print) IS - 1107-3756 (Linking) VI - 41 IP - 5 DP - 2018 May TI - Human umbilical cord mesenchymal stem cells inhibit proliferation of hepatic stellate cells in vitro. PG - 2545-2552 LID - 10.3892/ijmm.2018.3500 [doi] AB - The effect of human umbilical cord mesenchymal stem cells (hUC-MSCs) on the proliferation of hepatic stellate cells (HSCs) is largely unknown. The purpose of this study was to explore the mechanism of action of hUC‑MSCs on the proliferation of HSCs in vitro. The upper and lower double-cell co-culture system was established between hUC‑MSCs and HSCs in the experimental group. HSCs were cultured alone as a negative control group. Cell proliferation and apoptosis were determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and flow cytometry, respectively. Cell supernatants were harvested to determine the concentration of transforming growth factor-beta1 (TGF-beta1) by ELISA. mRNA and protein of TGF-beta1, Smad3 and Smad7 in HSCs were determined by reverse transcription-polymerase chain reaction and western blotting, respectively. In the co-culture group, the proliferation of HSCs was significantly inhibited compared with the negative control group at 24 and 48 h (p<0.05). Apoptosis of HSCs in the co-culture group increased compared with that in the negative control group, which was more obvious at 48 h (p<0.05). The concentration of TGF-beta1 in the co-culture group was significantly lower than in the HSCs cultured alone (p<0.05). After HSCs were co-cultured with hUC‑MSCs for 48 h, expression of TGF-beta1 and Smad3 mRNA and protein was reduced and expression of Smad7 mRNA and protein was increased compared with the negative control group (p<0.05). hUC‑MSCs inhibited proliferation of HSCs, possibly through inhibiting TGF-beta1 and Smad3 expression and increasing Smad7 protein expression. FAU - Zhang, Li-Ting AU - Zhang LT AD - Department of Infectious Diseases, The First Hospital of Lanzhou University, Lanzhou, Gansu 730000, P.R. China. FAU - Peng, Xue-Bin AU - Peng XB AD - Department of Infectious Diseases, The First Hospital of Lanzhou University, Lanzhou, Gansu 730000, P.R. China. FAU - Fang, Xue-Qin AU - Fang XQ AD - Department of Infectious Diseases, The Central Hospital of Baoji, Baoji, Shannxi 721008, P.R. China. FAU - Li, Jun-Feng AU - Li JF AD - Department of Infectious Diseases, The First Hospital of Lanzhou University, Lanzhou, Gansu 730000, P.R. China. FAU - Chen, Hong AU - Chen H AD - Department of Infectious Diseases, The First Hospital of Lanzhou University, Lanzhou, Gansu 730000, P.R. China. FAU - Mao, Xiao-Rong AU - Mao XR AD - Department of Infectious Diseases, The First Hospital of Lanzhou University, Lanzhou, Gansu 730000, P.R. China. LA - eng PT - Journal Article DEP - 20180216 PL - Greece TA - Int J Mol Med JT - International journal of molecular medicine JID - 9810955 RN - 0 (SMAD3 protein, human) RN - 0 (SMAD7 protein, human) RN - 0 (Smad3 Protein) RN - 0 (Smad7 Protein) RN - 0 (Transforming Growth Factor beta1) SB - IM MH - Apoptosis MH - Cell Line MH - *Cell Proliferation MH - Coculture Techniques MH - Gene Expression Regulation MH - Hepatic Stellate Cells/*cytology/metabolism MH - Humans MH - Mesenchymal Stem Cells/*cytology/metabolism MH - Smad3 Protein/analysis/genetics MH - Smad7 Protein/analysis/genetics MH - Transforming Growth Factor beta1/analysis/genetics MH - Umbilical Cord/*cytology/metabolism PMC - PMC5846650 COIS- Competing interests The authors declare that they have no competing interests. EDAT- 2018/02/28 06:00 MHDA- 2018/08/28 06:00 PMCR- 2018/02/16 CRDT- 2018/02/28 06:00 PHST- 2016/07/01 00:00 [received] PHST- 2018/01/22 00:00 [accepted] PHST- 2018/02/28 06:00 [pubmed] PHST- 2018/08/28 06:00 [medline] PHST- 2018/02/28 06:00 [entrez] PHST- 2018/02/16 00:00 [pmc-release] AID - ijmm-41-05-2545 [pii] AID - 10.3892/ijmm.2018.3500 [doi] PST - ppublish SO - Int J Mol Med. 2018 May;41(5):2545-2552. doi: 10.3892/ijmm.2018.3500. Epub 2018 Feb 16.